Qianlai Luo

722 citations
25 papers · 430 indexed · h-index 10
Topics
Viral-associated cancers and disorders (13 papers)Polyomavirus and related diseases (7 papers)Lymphoma Diagnosis and Treatment (6 papers)

In The Last Decade

Qianlai Luo

20 papers receiving 411 citations

Peers

Qianlai Luo
Comparison fields: 5 of 98
  • Oncology 126
  • Clinical Psychology 62
  • Communication 60
  • Sociology and Political Science 55
  • Social Psychology 53
Replace Simon Holding with:
Simon Holding Australia
Brittny C. Davis Lynn United States
Li‐Ling Huang United States
Kara P. Wiseman United States
Natalia Tumas Argentina
Cynthia A. Gelb United States
Abbey Diaz Australia
Donna Perez Australia
Arzu Tuna Türkiye
Qianlai Luo relative to Simon Holding Australia Simon Holding's profile →
Citations per field
00.5×10×13.5×
Simon Holding · 1×
Citations per year

Countries citing papers authored by Qianlai Luo

Since Specialization
Citations

This map shows the geographic impact of Qianlai Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianlai Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianlai Luo more than expected).

Fields of papers citing papers by Qianlai Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianlai Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianlai Luo. The network helps show where Qianlai Luo may publish in the future.

Co-authorship network of co-authors of Qianlai Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qianlai Luo. A scholar is included among the top collaborators of Qianlai Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianlai Luo. Qianlai Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 10
5 1
6 1
7 2
8 7
9 6
10 6
11 6
12 20
13 10
14 0
15 17
16 45
17 16
18 5
19 132
20 61

About Qianlai Luo

Qianlai Luo is a scholar working on Oncology, Transplantation and Complementary and alternative medicine, having authored 25 papers that have together received 430 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (13 papers), Polyomavirus and related diseases (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Communication (60 citations), Oncology (126 citations) and Complementary and alternative medicine (30 citations). Qianlai Luo has collaborated with scholars based in United States, Australia and Finland. Frequent co-authors include Xuemei Han, Jean-Baptiste Michel, Xuesong Han, Selby Jacobs, Gary Asher, Meredith S. Shiels, Yuming Guo, Jouni J. K. Jaakkola, Eric A. Engels and Shanshan Li. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026